Filter Results
:
(323)
Show Results For
-
All HBS Web
(323)
- People (1)
- News (131)
- Research (141)
- Multimedia (13)
- Faculty Publications (84)
Show Results For
-
All HBS Web
(323)
- People (1)
- News (131)
- Research (141)
- Multimedia (13)
- Faculty Publications (84)
- 24 Sep 2020
- News
The Race for a Vaccine
newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely...
View Details
- 17 Feb 2022
- News
What Can Actually Convince Vaccine Skeptics to Get Their Shots
- 16 Nov 2020
- News
Moderna Announces Promising Vaccine Trial Results
Moderna released promising news on the progress of their coronavirus vaccine this morning, noting that trials showed it to be 94.5% effective. “In this pandemic, what has been awful from a public health standpoint, an economic standpoint,...
View Details
- 24 Apr 2014
- News
Saving lives through new vaccine technology
Michael Schrader (MBA 2012) is on a mission to help keep millions of people around the world from dying needlessly. “Right now, 2.4 million people die every year from vaccine-preventable diseases,” says Schrader, cofounder and CEO of Vaxess Technologies. While the cost...
View Details
- 06 Apr 2021
- News
Day of 4 Million Vaccines Signals Sharp Turnaround for U.S.
- Article
Where America's Vaccine Triumph Fell Short
Kominers, Scott Duke. "Where America's Vaccine Triumph Fell Short." Bloomberg Opinion (April 10, 2021).
- 15 Jun 2020
- Video
Webinar: Science, Business & Vaccine Development to Combat the Pandemic.
- October 2012
- Teaching Note
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich
- 29 Nov 2020
- News
COVID-19 vaccine breakthroughs: What happens now?
- 02 Sep 2021
- News
I Expect COVID Vaccine Boosters to Be Mandated by Companies: Gimbel
- Winter 2022
- Article
Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities
By: Eric Budish, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast and Andrew A. Torkelson
By January 2022, the COVAX international vaccine collaboration had allocated over a billion vaccines to over 140 countries. We describe and review the allocation process chosen, which reflected both an objective of equitably distributing vaccines across the world and...
View Details
Keywords:
Vaccines;
Pandemics;
Health Care and Treatment;
Health Pandemics;
Distribution;
Supply Chain;
Equality and Inequality
Budish, Eric, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast, and Andrew A. Torkelson. "Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities." Oxford Review of Economic Policy 38, no. 4 (Winter 2022): 941–974.
- 09 Sep 2021
- News
Should Your Company Implement a Vaccination Mandate?
- 16 Mar 2020
- News
Moderna Announces Start of Coronavirus Vaccine Testing
- 09 Jun 2020
- Cold Call Podcast
In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?
- 17 Sep 2020
- News